Quote:
Originally Posted by CaptainYooh
Something in this story doesn't make any sense. I am not aware of the minute details of the drug patent systems in Canada and US; however, I believe that all new drug patents expire at some point and then their formulations are up for reproduction by generic drug manufacturers. The shelf life of a new patent is not that long, certainly less than 60 years. Large pharmaceuticals often circumvent this by introducing modifications to their patents and extending their shelf life. But, in general, a 60-yr old drug should be reproducible without patent violation. And, if nobody wants to manufacture it because of the low demand, then either the government needs to step in and do it themselves or, pay the piper that wants to do it. I do agree this guy looks very sleazy and unlikable, but ...
|
The US patent system has been increasingly under attack by various interest groups proposing longer patent periods. Funny enough, some of the biggest proponents of arguing for longer IP periods is Hollywood.
Although I cannot comment on the similarities so, don't roast me if I'm making a leap here.